7ª Prórroga + MODIFICACION Suministro de RAVULIZUMAB (ULTOMIRIS) solución inyectable, de distribución exclusiva para el Servicio de Farmacia del Hospital Clínico San Carlos de Madrid.
TED · 685056-2026Award noticeawardedNo deadline given
Value
Estimated—
Awarded€2,022,701 · 2,022,701.41 EUR
WinnerAlexion Pharma Spain, S.L.U
Who already wins at this buyer
Firms with recorded awards from HOSPITAL CLINICO SAN CARLOS DE MADRID in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| EPYCARDIO, S.L. | 2 | €1,179,875 | 2026-05-22 |
| ALNYLAM PHARMACEUTICALS SPAIN, S.L. | 1 | €1,357,948 | 2026-07-21 |
| NOVARTIS FARMACEUTICA, S.A | 1 | €1,255,311 | 2026-06-05 |
| BIOMED S A | INCARDIO S L | JOTEC CARDIOVASCULAR, S.L. | EDWARDS LIFESCIENCES, S.L. | Medtronic Ibérica, S.A. | 1 | €1,094,617 | 2026-05-08 |
| WERFEN ESPAÑA, S.A. | 1 | €1,037,250 | 2026-09-03 |
Full buyer profile: what HOSPITAL CLINICO SAN CARLOS DE MADRID buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
7ª Prórroga + MODIFICACION Suministro de RAVULIZUMAB (ULTOMIRIS) solución inyectable, de distribución exclusiva para el Servicio de Farmacia del Hospital Clínico San Carlos de Madrid.